Effect of early fasting and total parenteral nutrition support on the healing of incision and nutritional status in patients after sacrectomy

被引:8
|
作者
Gao, S. [1 ]
Zheng, Y. [2 ]
Liu, X. [3 ]
Tian, Z. [3 ]
Zhao, Y. [3 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Orthoped, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiol, 1 Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Tumor Hosp, Dept Orthoped, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
关键词
Complications; Sacral tumors; Sacrectomy; Total parenteral nutrition; RECONSTRUCTION; DIAGNOSIS; RESECTION; CANCER; TUMORS; OUTCOMES; DEFECTS; SURGERY; FLAPS; RISK;
D O I
10.1016/j.otsr.2018.02.006
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction: Surgical site infection is one of the most common complications for patients after sacrectomy, which often accompanied by poor wound healing, sinus formation and serious metabolic disturbance. Hypothesis: We tried to avoid the surgical site infection caused by feces during early period after surgery through early fasting and total parenteral nutrition (TPN) support, then compared the clinical results of these patients with other patients that received enteral nutrition (EN) early after sacrectomy. Methods: Methods: Forty-eight patients after sacrectomy (the level of sacrectomy above S-2) were randomly divided into two groups: TPN group and EN group. The patients of two groups received different nutrition support from the first day to the seventh day after surgery, then the factors such as nutritional and metabolic status after surgery, incidence of complications as well as the time of incision healing and hospitalization were observed. Results: The p-value of total serum protein, albumin, serum alanine aminotransferase, total bilirubin at seventh day after sacrectomy between TPN group and EN group is <0.0005. The p-value of hemoglobin at seventh day after sacrectomy between TPN group and EN group is 0.001. The p-value of total serum protein at fourteenth day after sacrectomy between TPN group and EN group is 0.003. The p-value of albumin and total bilirubin at fourteenth day after sacrectomy between TPN group and EN group is 0.001. The p-value of hemoglobin, serum alanine aminotransferase at fourteenth day after sacrectomy between TPN group and EN group is < 0.0005. The incidence of gastrointestinal complication and delay of apparition of feces in EN group were lower than that in TPN group (p = 0.041, p < 0.0005). The incidence of surgical site infection, the time of incision healing and hospitalization in TPN group were lower than that in EN group (p = 0.048, p = 0.008, p < 0.0005). Conclusions: The method of fasting and supported by TPN during the early period after sacrectomy contribute to the incision healing, meanwhile, it shortens the hospitalization time and abates the incidence of complications in patients after sacrectomy. Type of study: It is a comparative randomized study. Level of proof: High-powered prospective randomized trial. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 50 条
  • [21] Parenteral Nutrition and Nutritional Support of Surgical Patients: Reflections, Controversies, and Challenges
    Dudrick, Stanley J.
    Pimiento, Jose Mario
    SURGICAL CLINICS OF NORTH AMERICA, 2011, 91 (03) : 675 - +
  • [22] Nutritional support and parenteral nutrition in cancer patients: an expert consensus report
    J. A. Virizuela
    M. Camblor-Álvarez
    L. M. Luengo-Pérez
    E. Grande
    J. Álvarez-Hernández
    M. J. Sendrós-Madroño
    P. Jiménez-Fonseca
    M. Cervera-Peris
    M. J. Ocón-Bretón
    Clinical and Translational Oncology, 2018, 20 : 619 - 629
  • [23] Nutritional support and parenteral nutrition in cancer patients: An expert consensus report
    Ocon Breton, Maria Julia
    Luengo Perez, Luis Miguel
    Antonio Virizuela, Juan
    Alvarez Hernandez, Julia
    Jimenez Fonseca, Paula
    Cervera Peris, Mercedes
    Sendros Madrono, Maria Jose
    Grande, Enrique
    Camblor Alvarez, Miguel
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 : 17 - 23
  • [24] Nutritional support and parenteral nutrition in cancer patients: an expert consensus report
    Virizuela, J. A.
    Camblor-Alvarez, M.
    Luengo-Perez, L. M.
    Grande, E.
    Alvarez-Hernandez, J.
    Sendros-Madrono, M. J.
    Jimenez-Fonseca, P.
    Cervera-Peris, M.
    Ocon-Breton, M. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (05): : 619 - 629
  • [25] New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition
    Akbulut, Gamze
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (04) : 675 - 684
  • [26] NUTRITIONAL-STATUS OF PATIENTS WITH LUNG-CARCINOMA - THE EFFECT OF CHEMOTHERAPY AND PARENTERAL-NUTRITION
    SHIKE, M
    FELD, R
    EVANS, WK
    MARLISS, EB
    HARRISON, JE
    SHEPHERD, FA
    JEEJEEBHOY, KN
    CLINICAL RESEARCH, 1981, 29 (02): : A629 - A629
  • [27] NUTRITIONAL-STATUS OF PATIENTS WITH LUNG-CARCINOMA - THE EFFECT OF CHEMOTHERAPY AND PARENTERAL-NUTRITION
    SHIKE, M
    FELD, R
    EVANS, WK
    MARLISS, EB
    HARRISON, JE
    SHEPHERD, FA
    JEEJEEBHOY, KN
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (04): : 620 - 620
  • [28] Status of nutrition and nutritional support for acute stroke patients
    Cui, C
    Chen, X
    Zeng, J
    STROKE, 2004, 35 (06) : E212 - E212
  • [29] IMPACT OF THE CREATION OF A NUTRITIONAL SUPPORT TEAM ON THE QUALITY, SAFETY AND EFFECTIVENESS OF TOTAL PARENTERAL NUTRITION
    Lopez-Martin, C.
    Abiles, J.
    Garrido Siles, M.
    Faus Felipe, V.
    NUTRICION HOSPITALARIA, 2012, 27 (03) : 871 - 878
  • [30] Development of Clinical Application for a Nutritional Prescription Support System for Total Parenteral/Enteral Nutrition
    Masuda, Syuzo
    Oka, Ryusho
    Uwai, Koji
    Matsuda, Yumi
    Shiraishi, Tadashi
    Nakagawa, Yoshito
    Shoji, Tohru
    Mihara, Chie
    Takeshita, Mitsuhiro
    Ozawa, Koichiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (09): : 1077 - 1086